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Background: Ovarian endometriomas affect a substantial proportion of women of reproductive age who may have
a potential risk of diminished ovarian reserve (DOR) after ovarian cystectomy. Here, we investigated the risk factors
for pre-surgical DOR in patients with ovarian endometriomas and for DOR after laparoscopic ovarian cystectomy for
endometriomas and evaluated the feasibility of the pre-surgical prediction of post-surgical DOR based on the
Bologna criteria.
Methods: A total of 143 patients with ovarian endometriomas who underwent laparoscopic cystectomy from January
2009 to May 2015 at our hospital were prospectively enrolled and evaluated. Serum anti-Müllerian hormone (AMH)
concentrations were measured pre-surgically and at 3 and 6 months after surgery. In accordance with the Bologna
criteria, the patients whose AMH concentrations were <1.1 ng/mL before surgery and 3 or 6 months after surgery were
classified into pre- and post-surgical adverse DOR (aDOR) groups, respectively.
Results: Thirty-one (21.7 %) of 143 patients were classified as pre-surgical aDOR. Patient age and serum
follicle-stimulating hormone level were significantly positively correlated with pre-surgical aDOR [odds ratios (ORs), 1.26
and 1.16; p < 0.001 and p = 0.003, respectively]. Among the remaining 112 patients, 38 patients (33.9 %) had
post-surgical aDOR 3 and 6 months after surgery. Bilateral cystectomy was positively correlated with post-surgical aDOR
(at 3 months: OR, 4.7; p = 0.001; at 6 months: OR, 3.71; p = 0.006); conversely, pre-surgical serum AMH concentrations
were negatively correlated with post-surgical aDOR (at 3 months: OR, 0.65; p = 0.005; at 6 months: OR, 0.43; p < 0.001).
The optimal cut-off point of pre-surgical AMH concentrations for predicting aDOR at 3 and 6 months in the patients
undergoing unilateral cystectomy was 2.1 ng/mL. In contrast, the optimal cut-off points at 3 and 6 months in the
patients undergoing bilateral cystectomy were 3.0 and 3.5 ng/mL, respectively.
Conclusions: Our data suggest that the pre-surgical serum AMH concentrations and bilateral cystectomy are
significant factors for the risk of aDOR following surgery and that predicting post-surgical aDOR according to the
Bologna criteria could be feasible using pre-operative measurements of serum AMH concentrations.
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The current laparoscopic procedures for ovarian endo-
metriomas, which affects 17 %–44 % of women with
endometriosis [1], include ovarian cystectomy, ablation
of the cyst wall and fenestration of cysts [2]. According
to the European Society of Human Reproduction and
Embryology (ESHRE) guidelines, ovarian cystectomy is
preferred for the secondary prevention of endometriosis-
associated symptoms and for increasing the spontaneous
pregnancy rate [3]. However, both the guidelines and
previous studies suggested a possible post-surgical re-
duction in the ovarian reserve, which indicates that folli-
cles are inadvertently removed by the stripping of the
cyst wall [4–7]. The serum concentration of anti-
Müllerian hormone (AMH) is a highly sensitive marker
of ovarian reserve, and, owing to its stability, it can be
used to evaluate ovarian reserve after surgery to treat
ovarian endometriomas [8, 9]. Serum AMH concentra-
tions are known to significantly decrease after cystec-
tomy for ovarian endometriomas.
The ESHRE working group established the Bologna
criteria in 2011, which proposed a definition for the
term poor ovarian responder (POR) to controlled ovar-
ian stimulation for assisted reproductive technology
(ART) [10]. A recent study reported that, based on the
Bologna criteria, women diagnosed with POR after cyst-
ectomy for ovarian endometriomas had significantly
lower clinical pregnancy and live birth rates after in vitro
fertilisation (IVF) than women who were idiopathic
PORs [11]. The study suggested that some patients with
ovarian endometriomas have a potential risk of dimin-
ished ovarian reserve (DOR) and becoming a POR fol-
lowing ovarian cystectomy. However, the potential
incidence and the risk factors have not yet been ad-
equately investigated.
The aims of the present study were to investigate the
factors associated with DOR and the potential risk of be-
coming a POR before and after laparoscopic cystectomy
of ovarian endometriomas, and to evaluate the feasibility
of pre-surgical prediction of post-surgical DOR accord-
ing to the Bologna criteria.
Methods
Patients and recruitment
Patients who were admitted to our hospital from January
2009 to May 2015 for symptomatic ovarian endome-
trioma with a cyst >4 cm in diameter were enrolled in
the present study. The disorder was diagnosed using
transvaginal ultrasound and pelvic magnetic resonance
imaging. The inclusion criteria were as follows: 1) non-
pregnant patients; 2) age under 45 years with a regular
menstrual cycle; 3) absence of any leiomyoma involving
the cavity or intramural leiomyoma >3 cm in diameter;
4) absence of any other bleeding diseases; 5) absence ofendocrine disorders, including thyroid dysfunction,
hyperprolactinemia and Cushing’s syndrome; 6) no pre-
vious history of abdominal surgery; 7) absence of malig-
nant ovarian diseases and 8) no previous history of
hormonal treatment within 3 months before blood col-
lection. The diameters of the ovarian cysts were mea-
sured in all the patients by ultrasound before surgery.
Definitions of pre-and post-surgical adverse DOR
In accordance with the Bologna criteria, AMH concen-
trations already decreased to <1.1 ng/mL before surgery
were defined as pre-surgical adverse DOR (aDOR) with
a potential risk of the patient becoming a POR. AMH
concentrations that were >1.1 ng/mL before surgery but
decreased to <1.1 ng/mL at 3 or 6 months after laparo-
scopic cystectomy were defined as post-surgical aDOR.
None of the patients underwent postoperative hormonal
therapy until 6 months after surgery.
Measurements
The diameters of the ovarian cysts were measured in
all patients using ultrasound before surgery; the con-
centrations of serum AMH, luteinising hormone (LH),
follicle-stimulating hormone (FSH), estradiol and can-
cer antigen 125 (CA125) were also measured. In pa-
tients with bilateral ovarian endometriomas, the total
diameter was calculated as the sum of the diameters
of both cysts. Serum AMH concentrations were also
measured at 3 and 6 months after surgery. The sera,
obtained from the blood samples by centrifugation
(1,400 × g, 10 min) to separate the cellular contents
and debris, were transferred into sterile polypropylene
tubes and then cryopreserved at −80 °C until analysis.
The serum AMH concentrations were measured using
an enzyme immunoassay kit according to the manu-
facturer’s instructions (EIA AMH/MIS; Immunotech,
Marseille, France). The intra- and inter-assay coeffi-
cients of variation for the AMH assay were below
12.3 and 14.2 %, respectively.
Surgical procedures
All surgical procedures were performed by the same
skilled surgeon (J.K.). The patient was placed in a 30° re-
verse Trendelenburg lithotomy position under general
anaesthesia, and endotracheal intubation was then per-
formed, with a pneumoperitoneum created using CO2
insufflation with an umbilical 11-mm trocar (VersaStep™;
Covidien, Mansfield, MA, USA), approached via the
closed method and maintained at a pressure of
10 mmHg. Under observation using a 10-mm rigid lap-
aroscope (Endoeye™; Olympus, Tokyo, Japan) inserted
through the umbilical trocar, three additional sites for
trocar (VersaStep™; Covidien) insertion were made as
follows: two 5-mm sites at 2 cm above the anterior
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the umbilicus on the left axillary line. A uterine manipu-
lator (Ethicon, Somerville, NJ, USA) was inserted in the
uterus of the patient, and the severity of pelvic endomet-
riosis was assessed using a scoring system according to
the revised American Society of Reproductive Medicine
(Re-ASRM) classification immediately before initiating
the laparoscopic procedures [12]. Furthermore, patients
underwent adhesiolysis of the obliterated cul-de-sac
when necessary. After the cyst was aspirated and
drained, adhesions between the cyst wall and the pelvic
wall or bowel were lysed, and an 18-gauge infusion nee-
dle was used to inject diluted vasopressin (Pitressin®;
Goldshield Pharmaceuticals, Croydon, Surrey, UK; 0.1
U/mL: 10 U diluted with 100 mL saline) from the inner
surface of the cyst wall into the subcapsular space de-
pending on the diameter of the incised ovarian cyst. The
incision was further extended to strip the cyst wall from
the surrounding normal ovarian cortex as gently as pos-
sible using two atraumatic grasping forceps for traction
and counter-traction after identifying the cleavage plane.
After completion of the excision of the cyst capsule, 3–0
absorbable sutures (PolySorb®; Covidien) were used for
approximation of the ovarian edges and bleeding control.
Electrocoagulation with a monopolar (30-W) needle knife
for haemostasis was minimally used before approximation.
The total duration of the surgery was calculated as the
sum of the amounts of elapsed time between the skin inci-
sion and the start of the pneumoperitoneum, the intra-
and extracorporeal manipulations and the skin closure
after finishing the pneumoperitoneum.
Statistical analyses
Statistical analyses were performed using the computer
software package IBM SPSS Statistics version 20 (IBM,
Armonk, NY, USA). A Kolmogorov–Smirnov test was
performed to analyse the normality of the respective pa-
rameters. Unpaired Student’s t-tests or the Mann–Whit-
ney U-test was performed to compare consecutive
variables, and chi-square tests or Fisher’s exact test was
performed to compare categorical variables. The results
are expressed as the mean ± standard deviation and 95 %
confidence interval (CI) or median and range. Attribu-
tion analysis of the factors influencing pre- and post-
surgical aDOR was followed by forward stepwise variable
selection; logistic regression analysis was performed to
minimise the effects of confounding factors. Receiver
operating characteristic (ROC) curves were used to
obtain the area under the curve (AUC) as well as the
sensitivity and specificity for the predictive value of
pre-operative AMH. The highest Youden index (sensi-
tivity + specificity - 1) was considered as the optimal
cut-off point for outcome prediction. A p value of
<0.05 was considered statistically significant. Amongthe patients, the cumulative spontaneous pregnancy
rate of infertile patients was analysed using the
Kaplan–Meier method. Patients who were lost to
follow-up or who underwent ART during the observa-
tion period until 6 months after surgery were defined
as censored data. The cumulative pregnancy rates be-
tween the groups were compared using the log-rank
test. We also calculated odds ratios (ORs).
Results
A flow diagram of the subjects analysed in this study is
shown in Fig. 1. The following analyses were conducted:
1) analysis I, to evaluate influencing factors associated
with pre-surgical aDOR among 143 patients who under-
went laparoscopic cystectomy for endometriomas; 2)
analysis II, to evaluate influencing factors associated with
post-surgical aDOR at 3 and 6 months after surgery in
112 patients without pre-surgical aDOR and optimal
cut-off points of the pre-surgical AMH concentration to
predict post-surgical aDOR at 3 and 6 months after
surgery by ROC curve analysis and 3) analysis III, to
evaluate cumulative spontaneous pregnancy rates at
24 months after surgery in the aDOR and non-aDOR
groups classified according to serum AMH concentra-
tions at 6 months after surgery in 35 patents who tried
to achieve spontaneous pregnancy after surgery.
Assessments of pre-surgical aDOR in patients with
ovarian endometriomas
Among the 143 patients, 31 (21.7) and 112 (78.3 %) were
placed into the pre-surgical aDOR and non-DOR
groups, respectively. Table 1 shows the pre-surgical pa-
tient backgrounds of both groups. Patient age, gravidity,
parity, occurrence of bilateral cysts and serum LH, FSH
and estradiol concentrations were significantly higher in
the pre-surgical aDOR group than in the non-DOR
group. Among these significant variables, age and serum
FSH concentration were positively correlated with pre-
surgical aDOR. The serum AMH concentrations of 31
patients in the pre-surgical aDOR group before surgery
and at 3 and 6 months after surgery were significantly
lower than those in the non-DOR group (Table 2).
Factors influencing post-surgical aDOR after ovarian
cystectomy
Postsurgical serum AMH concentrations at 3 months
after surgery of all 112 patients in the pre-surgical non-
aDOR group decreased below the pre-surgical concen-
trations. Among them, 38 (33.9) and 74 (66.1 %) were
classified at 3 months after surgery into the post-surgical
aDOR and non-aDOR groups, with serum AMH con-
centrations of 0.6 ± 0.4 and 3.2 ± 2.2 ng/mL, respectively.
Table 3 shows the comparisons of the patient background
characteristics and peri-surgical findings between the
Fig. 1 Diagram depicting flow of subjects through the study. Abbreviations: ART: assisted reproductive technology; DOR: diminished
ovarian reserve
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after surgery. Univariate analysis revealed significant dif-
ferences in age at surgery, the number of patients who
underwent bilateral cystectomy, pre-surgical serum AMH
concentrations and blood loss during surgery. Among
these significant variables, bilateral cystectomy was posi-
tively correlated with aDOR at 3 months after surgery;
conversely, the pre-surgical serum AMH concentrationTable 1 Factors associated with pre-surgical adverse DOR in patient
Characteristics Univariate analysis
Adverse DOR (n = 31) No
Patient characteristics
Age (years) 37.9 ± 4.1 (36.4–39.4) 33
Gravidity (%) 0.5 ± 0.8 (0.2–0.7) 0.2
Parity (%) 0.4 ± 0.6 (0.1–0.6) 0.1
Body mass index (kg/m2) 22.0 ± 6.5 (19.6–24.4) 21
Laterality of cysts
Unilateral (%) 10 (32.3) 64
Bilateral (%) 21 (67.7) 48
Total size of ovarian cyst (mm) 83.1 ± 32.2 (71.3–94.9) 73
Pre-surgical serum hormone concentrations
LH (mIU/mL) 9.7 ± 9.9 (6.1–13.4) 6.2
FSH (mIU/mL) 10.3 ± 7.0 (7.7–12.8) 6.5
Estradiol (pg/mL) 134.5 ± 167.1 (73.2–195.8) 72
CA125 (U/mL) 90.1 ± 104.7 (51.7–128.5) 68
Abbreviations: CA125 cancer antigen 125, CI confidence interval, DOR diminished ov
OR odds ratio
Data are expressed as mean ± standard deviation (95 % CI) or number (percentage)was negatively correlated with aDOR at 3 months after
surgery.
At 6 months after surgery, serum AMH concentra-
tions of 99 (88.4 %) of 112 patients of the pre-surgical
non-DOR group decreased below the pre-surgical con-
centrations. Among the 38 patients in the aDOR group
at 3 months after surgery, 30 (78.9) and 8 (21.1 %) were
in the aDOR and non-aDOR groups, respectively, ats scheduled for laparoscopic cystectomy for endometriomas
Multivariate analysis
n-DOR (n = 112) P value OR (95%CI) P value
.5 ± 4.9 (32.6–34.4) <0.001 1.26 (1.11–1.43) <0.001
± 0.5 (0.1–0.2) 0.02 − −
± 0.4 (0.03–0.2) 0.02 − −
.4 ± 5.0 (20.5–22.4) 0.64
(57.1) 0.01 − −
(42.9)
.1 ± 27.5 (67.9–78.2) 0.09
± 8.4 (4.6–7.8) 0.047 − −
± 3.5 (5.8–7.1) <0.001 1.16 (1.05–1.28) 0.003
.3 ± 87.2 (56.0–88.6) 0.01 − −
.9 ± 53.0 (58.9–78.8) 0.12
arian reserve, FSH follicle-stimulating hormone, LH luteinising hormone,
of patients
Table 2 Comparison of pre- and post-surgical serum AMH concentrations between pre-surgical adverse DOR and non-DOR patients
with ovarian endometriomas
AMH (ng/ml) p
valueAdverse DOR (n = 31) Non-DOR (n = 112)
Presurgical 0.7 ± 0.3 (0.6–0.8) 4.0 ± 2.8 (3.5–4.5) <0.001
3 months after surgery 0.4 ± 0.4 (0.3–0.6) 2.3 ± 2.2 (1.9–2.8) <0.001
6 months after surgery 0.5 ± 0.4 (0.4–0.7) 2.3 ± 2.1 (1.9–2.7) <0.001
Abbreviations: AMH anti-Müllerian hormone, CI confidence interval, DOR diminished ovarian reserve. Data are expressed as mean ± standard deviation (95 %
confidence interval) or number (percentage) of patients
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non-aDOR group at 3 months after surgery, 8 (10.8) and
66 (90.2 %) were in the aDOR and non-aDOR groups,
respectively, at 6 months after surgery. Finally, at
6 months after surgery, 38 (33.9) and 74 patients
(66.1 %) were in the aDOR and non-aDOR groups with
serum AMH concentrations of 0.8 ± 0.7 and 3.0 ±
2.1 ng/mL, respectively. Table 4 shows comparisons of
patient backgrounds characteristics and peri-surgical
findings between the aDOR and non-aDOR groups at
6 months after surgery. Univariate analysis revealed sig-
nificant differences in the number of patients who
underwent bilateral cystectomy, pre-surgical serum
AMH concentrations and Re-ASRM score. Logistic re-
gression analysis revealed that bilateral cystectomy andTable 3 Factors associated with post-surgical adverse DOR at 3 mon
Univariate analysis
Adverse DOR (n = 38) Non-a
Patient characteristics
Age (years) 34.9 ± 5.0 (33.2–36.5) 32.8 ±
Gravidity (%) 0.2 ± 0.6 (0.01–0.4) 0.1 ±
Parity (%) 0.2 ± 0.5 (0.2–0.3) 0.1 ±
Body mass index (kg/m2) 21.8 ± 4.6 (20.2–23.3) 21.3 ±
Laterality of cysts
Unilateral (%) 13 (34.2) 51 (68
Bilateral (%) 25 (65.8) 23 (31
Total size of ovarian cyst (mm) 79.9 ± 35.0 (68.4–91.4) 69.6 ±
Pre-surgical serum hormone concentrations
LH (mIU/mL) 4.5 ± 4.0 (3.2–5.8) 7.0 ±
FSH (mIU/mL) 6.4 ± 2.6 (5.6–7.3) 6.5 ±
Estradiol (pg/mL) 79.4 ± 93.3 (48.7–110.1) 68.7 ±
CA125 (U/mL) 65.5 ± 44.2 (50.9–80.0) 70.6 ±
AMH (ng/mL) 2.8 ± 1.7 (2.2–3.4) 4.6 ±
Peri-surgical findings
Re-ASRM score 60.9 ± 32.1 (50.4–71.4) 49.4 ±
Total surgical duration (min) 91.5 ± 40.8 (78.1–104.9) 81.9 ±
Total blood loss (mL) 40.2 ± 46.1 (25.0–55.3) 23.9 ±
Abbreviations: AMH anti-Müllerian hormone, CA125 cancer antigen 125, CI confiden
LH luteinising hormone, OR odds ratio, Re-ASRM revised American Society of Reprod
Data are expressed as mean ± standard deviation (95 % CI) or number (percentage)the pre-surgical serum AMH concentrations significantly
influenced the development of aDOR 6 months after
surgery, which were the same significant factors as at
3 months after surgery.
Detection of optimal cut-off points of pre-surgical AMH
concentrations
Because the pre-surgical AMH concentrations signifi-
cantly contributed to the likelihood of a patient having
post-surgical aDOR at 3 and 6 months after surgery, as
assessed by logistic regression analysis, we investigated
the optimal cut-off points of the pre-surgical AMH con-
centration using ROC curves to predict post-surgical
aDOR due to ovarian cystectomy. Figure 2 shows the
ROC curves of the pre-surgical AMH concentrations ofths after laparoscopic cystectomy
Multivariate analysis
dverse DOR (n = 74) P value OR (95 % CI) P value











3.1 (3.9–5.3) 0.001 0.65 (0.48–0.88) 0.005
27.5 (43.0–55.7) 0.05
32.0 (74.5–89.3) 0.18
26.8 (17.7–30.1) 0.02 − −
ce interval, DOR diminished ovarian reserve, FSH follicle-stimulating hormone,
uctive Medicine
of patients
Table 4 Factors associated with post-surgical adverse DOR at 6 months after laparoscopic cystectomy
Variables Univariate analysis Multivariate analysis
Adverse DOR (n = 38) Non-adverse DOR (n = 74) P value OR (95 % CI) P value
Patient characteristics
Age (years) 34.6 ± 5.0 (33.0–36.3) 33.0 ± 4.8 (31.8–34.1) 0.09
Gravidity 0.2 ± 0.6 (0.03–0.5) 0.1 ± 0.4 (0.03–0.2) 0.30
Parity 0.2 ± 0.6 (0.1–0.6) 0.1 ± 0.3 (0–0.2) 0.15
Body mass index (kg/m2) 21.7 ± 4.5 (20.2–23.2) 21.3 ± 5.2 (20.1–22.6) 0.73
Laterality of cysts
Unilateral 15 (39.5) 49 (66.2) 0.007 3.71 (1.45–9.51) 0.006
Bilateral 23 (60.5) 25 (33.8)
Total size of ovarian cyst (mm) 75.4 ± 32.9 (64.6–86.2) 71.9 ± 24.4 (66.2–77.5) 0.52
Pre-surgical serum hormone concentrations
LH (mIU/mL) 4.7 ± 4.0 (3.4–6.0) 6.9 ± 10.0 (4.6–9.2) 0.18
FSH (mIU/mL) 6.7 ± 2.4 (5.9–7.5) 6.4 ± 3.9 (5.4–7.3) 0.67
Estradiol (pg/mL) 74.1 ± 89.3 (44.8–103.4) 71.4 ± 86.7 (51.3–91.5) 0.88
CA125 (U/mL) 71.3 ± 48.5 (55.4–87.3) 67.6 ± 55.4 (54.8–80.4) 0.72
AMH (ng/mL) 2.5 ± 1.2 (2.1–2.9) 4.8 ± 3.1 (4.0–5.5) <0.001 0.43 (0.27–0.67) <0.001
Peri-surgical findings
Re-ASRM score 61.8 ± 33.7 (50.8–72.9) 48.9 ± 26.3 (42.8–55.0) 0.03 − −
Total surgical duration (min) 89.8 ± 40.8 (76.4–103.2) 82.8 ± 32.3 (75.3–90.2) 0.32
Total blood loss (mL) 37.4 ± 45.5 (22.5–52.4) 25.4 ± 28.0 (18.9–31.8) 0.09
Abbreviations: AMH anti-Müllerian hormone, CA125 cancer antigen 125, CI confidence interval, DOR diminished ovarian reserve, FSH follicle-stimulating hormone,
LH luteinising hormone, OR odds ratio, Re-ASRM revised American Society of Reproductive Medicine
Data are expressed as mean ± standard deviation (95 % CI) or number (percentage) of patients
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who underwent bilateral cystectomy at 3 and 6 months
after surgery. At 3 months after surgery, the optimal
cut-off points of the pre-surgical AMH concentrations
of the patients who underwent unilateral cystectomy and
those who underwent bilateral cystectomy were 2.1 ng/
mL [AUC, 0.83 (95 % CI, 0.68–0.97); sensitivity 92.2 %,
specificity 76.9 %; p = 0.001; Fig. 2a] and 3.0 ng/mL
[AUC, 0.72 (95 % CI, 0.57– 0.87); sensitivity 69.6 %, spe-
cificity 76.0 %; p = 0.01; Fig. 2b], respectively, and at
6 months after surgery, the respective optimal cut-off
points were 2.1 ng/mL [AUC, 0.85 (95 % CI, 0.73–0.97);
sensitivity 89.8 %, specificity 73.3 %; p < 0.001; Fig. 2c]
and 3.5 ng/mL [AUC, 0.80 (95 % CI, 0.67–0.93); sensitiv-
ity 68.0 %, specificity 91.3 %; p < 0.001; Fig. 2d].
Impact of post-surgical aDOR on spontaneous pregnancy
after surgery
Thirty-nine of the 112 patients in the pre-surgical non-
DOR group desired to have a child following surgery.
Four patients who desired to undergo ART immediately
after the 6-month follow-up period were excluded from
the analysis of the cumulative spontaneous pregnancy
rate. Among the 35 patients remaining, 9 (25.7) and 26
(74.3 %) were placed in the post-surgical aDOR andnon-aDOR groups, respectively, according to their
serum AMH concentrations 6 months after surgery.
Table 5 shows comparisons of patient background char-
acteristics and serum AMH concentrations before sur-
gery and at 3 and 6 months after surgery between the
two groups. Although there were no significant differ-
ences in patient age and ovarian cyst laterality, the
serum AMH concentration at each period was signifi-
cantly lower in the aDOR group than in the non-aDOR
group. Figure 3 shows the cumulative spontaneous preg-
nancy rates of the two groups at 18 months after the 6-
month post-surgical measurements of serum AMH
concentrations. The cumulative spontaneous pregnancy
rate of the aDOR group was significantly lower than that
of the non-aDOR group (14.3 % vs. 59.2 %, p = 0.04).
Discussion
The results of the present study demonstrate that age and
pre-surgical serum FSH concentrations were significantly
associated with pre-surgical aDOR and that pre-surgical
serum AMH concentrations and bilateral cystectomy were
significant factors influencing the likelihood of a patient
having post-surgical aDOR at 3 and 6 months after sur-
gery. The optimal cut-off points of the pre-surgical AMH
concentration to predict post-surgical aDOR due to
Fig. 2 Receiver operating characteristic curves of pre-surgical anti-Müllerian hormone (AMH) concentrations for predicting diminished ovarian reserve
at 3 and 6 months after surgery. The optimal cut-off points of the pre-surgical AMH concentrations at 3 and 6 months in the patients with unilateral
cystectomy were 2.1 ng/mL (a, b). In contrast, the optimal cut-off points at 3 and 6 months in the patients undergoing bilateral cystectomy were 3.0
and 3.5 ng/mL, respectively (c, d)
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termined. In addition, the cumulative spontaneous preg-
nancy rate was significantly lower in the post-surgical
aDOR group than in the non-aDOR group at 6 months
after surgery.
As evaluated by serum AMH concentrations, the re-
duction of ovarian reserve after ovarian cystectomy for
endometriomas is inevitable. In our study population,
21.7 % of the patients were classified in the pre-surgical
aDOR group based on the Bologna criteria. A decline inserum AMH concentration is highly correlated with the
increasing age in women [13, 14]. Our data suggested
that the ovarian reserve of aged patients with ovarian
endometriomas was already diminished before surgery;
thus, it is presumed that serum AMH concentrations in
patients who have intrinsically low AMH concentrations
would be further diminished. Therefore, the assessment
of pre-surgical ovarian reserve for predicting further
post-surgical decline of ovarian reserve could be more
reliable if the serum AMH concentrations would be
Table 5 Comparison of characteristics of adverse and non-adverse DOR infertile patients classified by serum AMH concentrations at
6 months after laparoscopic cystectomy
Adverse DOR (n = 9) Non- adverse DOR (n = 26) P value
Age (years) 33 (29–39) 34 (26–39) 0.64
Laterality of cysts
Unilateral (%) 5 (55.6) 16 (61.5) 0.76
Bilateral (%) 4 (44.4) 10 (38.5)
Serum AMH concentrations (ng/mL)
Before surgery 2.5 (1.7–3.4) 3.5 (1.5–10.5) 0.02
3 months after surgery 0.5 (0.1–2.3) 2.3 (0.4–6.1) <0.001
6 months after surgery 0.6 (0.1–1.1) 2.1 (1.1–9.1) <0.001
Abbreviations: AMH anti-Müllerian hormone, CI confidence interval, DOR diminished ovarian reserve
Data are expressed as median (range) or number (percentage) of patients
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FSH concentration, which is a conventional ovarian re-
serve marker.
Several previous studies demonstrated that bilateral
ovarian cystectomy is a significant factor associated with
the decline of serum AMH concentrations after cystec-
tomy for ovarian endometriomas [15–17]. The results of
the present study revealed that pre-surgical AMH con-
centration is a crucial factor for the decline in serum
AMH concentrations after unilateral and bilateral ovar-
ian cystectomy. We believe that the post-surgical ovarian
reserve after ovarian cystectomy for endometriomas de-
pends on the pre-surgical potential of the ovarian re-
serve. In addition, it is thought that the optimal cut-off
points of the pre-surgical serum AMH concentrations
determined in the present study will be valuable for the
pre-surgical prediction of DOR leading to patientsFig. 3 Cumulative probability of spontaneous pregnancy rate 6 months aft
(DOR) group (dotted line) and non-adverse DOR group (solid line)becoming PORs. Previous studies have reported that the
serum AMH concentrations in most patients who
underwent a cystectomy for ovarian endometriomas de-
creased immediately after surgery and that the concen-
trations in some patients continuously decreased after
the immediate reduction [18, 19]. The authors of these
previous studies hypothesised that the continuous de-
cline of the AMH concentrations could be attributed to
vascular compromise, although the mechanisms are
unknown. Our results showed that the cut-off point of
the pre-surgical AMH concentrations in patients who
underwent bilateral ovarian cystectomy at 6 months
after surgery was increased compared with that at
3 months after surgery and that these cut-off points
were higher at both 3 and 6 months compared with the
concentrations of those who underwent unilateral ovar-
ian cystectomy. We believe that these declines in theer laparoscopic cystectomy in the adverse diminished ovarian reserve
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who underwent bilateral cystectomy were due to a lower
rate of recovery or a continuous decrease in AMH con-
centration because of the extended ovarian ischemia
resulting from the bilateral surgery.
Meticulous surgical techniques for the excision of the
capsule of ovarian endometrioma to find a correct cleav-
age plane and to achieve adequate haemostasis by coagu-
lations using an energy devise are important for
preserving the ovarian reserve [20]. In addition, an alter-
native management to cystectomy for ovarian endome-
triomas may be better for patients in whom further
decline of the ovarian reserve should be prevented. Less
reduction in serum AMH concentrations and antral fol-
licle count (AFC) was observed when vaporising internal
cyst walls using a CO2 laser as the source of energy com-
pared with the excision of the cyst wall because the CO2
laser could vaporize only the filmy superficial internal lin-
ing up to 1.0 to 1.5 mm of the cyst wall [21]. However,
higher recurrence rate after the vaporization remains de-
batable. Donnez et al. [22] reported that the ovarian vol-
ume and AFC did not significantly different between the
operated ovary by combining excision and vaporization
using CO2 laser and the contralateral unaffected ovary,
with a low recurrence rate at short-term follow-up. In
contrast, for patients who already have a decreased ovar-
ian reserve before surgery and who desire pregnancy, ART
may be more suitable because it has been reported that
IVF outcomes, including oocyte retrieval and pregnancy,
are promising even though the responsiveness of ovarian
hyperstimulation may be decreased owing to the presence
of the ovarian endometriomas [23]. Therefore, further re-
search is required to examine whether these alternative
managements instead of cystectomy are feasible for avoid-
ing the impairment of future fertility in the predicted
post-surgical DOR patients who have a potential risk for
being post-surgical PORs.
The results of the present study demonstrated that the
cumulative spontaneous pregnancy rate was significantly
lower in the post-surgical aDOR group at 6 months after
surgery than in the post-surgical non-aDOR group; the
rate at 18 months after the 6-month post-surgical mea-
surements of serum AMH concentrations was approxi-
mately 60 % in the post-surgical non-aDOR group.
Although the Bologna criteria define PORs with respect
to ART outcomes, our data indicate that post-surgical
DOR based on the criteria are reflected in the spontan-
eous pregnancy rate after cystectomy of ovarian endo-
metriomas; this rate might not have been as low if the
patients had not become PORs post-surgically. Vercellini
et al. reported that the spontaneous pregnancy rate after
ovarian cystectomy for endometriomas in infertile pa-
tients ranged from 30 % to 67 %, and they concluded
that the pregnancy rate 12 months after surgery inpatients who underwent surgery for ovarian endometrio-
mas could be hypothetically estimated to be not greater
than 25 % owing to the multiple confounding factors of
the studies in this field, including selection and publica-
tion bias [24]. Although the actual spontaneous preg-
nancy rate after ovarian cystectomy for endometriomas
is debatable, the variability of this rate in previous stud-
ies might be related to the heterogeneity of the patients
who experience difficulty getting pregnant owing to the
degree of DOR in each study.
One limitation of our study is that we did not examine
other markers of ovarian reserve. AFC is significantly
correlated with serum AMH concentrations and is a reli-
able marker of the ovarian reserve [25]; however, the
correlation was slightly altered when compared between
operated and contralateral healthy ovary after cystec-
tomy for unilateral ovarian endometrioma. Ercan et al.
[23] demonstrated that AFC of the operated ovary sig-
nificantly decreased compared with that of the non-
operated ovary, although serum AMH concentrations
did not significantly change at 3 months after laparo-
scopic unilateral cystectomy. Furthermore, meta-analysis
for ovarian reserve after excisional surgery demonstrated
that the ovarian reserve of the operated ovary, evaluated
using AFC, was not significantly reduced after surgery,
although AFC of the operated ovary after surgery was
lower than that of the non-operated ovary [26]. More-
over, they stated that AFC is more accurate as a marker
for ovarian reserve than AMH concentration because
AFC directly indicates the ovarian reserve expressed by
each single ovary. Conversely, AMH expresses the ovar-
ian reserve of both ovaries, where a balancing effect of a
healthy ovary may compensate for a reduced ovarian re-
serve in the contralateral affected ovary. Furthermore,
the AMH values do not represent the quality of the oo-
cytes. As the Bologna criteria define POR with respect to
patient age, which is an oocyte quality-related factor, and
to the responsiveness to ovarian stimulation, the out-
comes of ART for these DOR patients may differ de-
pending on the definitions used. Therefore, it is thought
that other markers of ovarian reserve should also be
evaluated to assess the reproducibility of our data.
Conclusions
Laparoscopic cystectomy for ovarian endometrioma is
an advanced surgical procedure that improves the symp-
toms of severe pain caused by conditions such as dys-
menorrhoea and dyspareunia and results in a lower
recurrence rate of ovarian cysts. However, a post-
surgical reduction in ovarian reserve due to the excision
of ovarian endometriomas is inevitable. Our study indi-
cates that patients with pre-surgical aDOR could be
identified and that the potential risk of being post-
surgical PORs could be predicted by using optimal cut-
Ozaki et al. Journal of Ovarian Research  (2016) 9:37 Page 10 of 10off points of the pre-surgical AMH concentrations.
These predictions will allow clinicians to select alterna-
tive therapies to prevent further decline of ovarian re-
serve, especially for infertile patients with ovarian
endometriomas.
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